Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for DGI Biotechnologies, LLC's Facility in Edison, NJ, 25613 [E6-6505]

Download as PDF Federal Register / Vol. 71, No. 83 / Monday, May 1, 2006 / Notices NUCLEAR REGULATORY COMMISSION [Docket No. 030–34437] Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for DGI Biotechnologies, LLC’s Facility in Edison, NJ Nuclear Regulatory Commission. ACTION: Notice of Availability. AGENCY: FOR FURTHER INFORMATION CONTACT: Joseph Nick, Commercial and R&D Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale Road, King of Prussia, Pennsylvania 19406, telephone (610) 337–5056, fax (610) 337–5269; or by e-mail: JLN@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The U.S. Nuclear Regulatory Commission (NRC) is considering the issuance of a license amendment to DGI Biotechnologies, LLC (DGI) for Materials License No. 29–30389–01, to authorize release of its facility in Edison, New Jersey for unrestricted use and terminate the license. NRC has prepared an Environmental Assessment (EA) in support of this proposed action in accordance with the requirements of 10 CFR part 51. Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. The amendment will be issued following the publication of this Notice. cchase on PROD1PC60 with NOTICES II. EA Summary The purpose of the proposed action is to authorize the release of the licensee’s Edison, New Jersey facility for unrestricted use and terminate the license. DGI was authorized by NRC from 1997 to use radioactive materials for research and development purposes at the site. In 2003, DGI ceased operations with licensed materials at the Edison site and the DGI facility was taken over by Antyra, Inc. (Antyra). On September 28, 2005, Antyra requested that NRC release the facility for unrestricted use. Antyra has conducted surveys of the facility and provided information to the NRC to demonstrate that the site meets the license termination criteria in subpart E of 10 CFR part 20 for unrestricted release. The NRC staff has prepared an EA in support of the license amendment. The facility was remediated and surveyed prior to the licensee requesting the license amendment. The NRC staff has reviewed the information and final VerDate Aug<31>2005 17:38 Apr 28, 2006 Jkt 208001 status survey submitted by Antyra. Based on its review, the staff has determined that there are no additional remediation activities necessary to complete the proposed action. Therefore, the staff considered the impact of the residual radioactivity at the facility and concluded that since the residual radioactivity meets the requirements in subpart E of 10 CFR part 20, a Finding of No Significant Impact is appropriate. III. Finding of No Significant Impact The staff has prepared the EA (summarized above) in support of the license amendment to terminate the license and release the facility for unrestricted use. The NRC staff has evaluated Antyra’s request and the results of the surveys and has concluded that the completed action complies with the criteria in subpart E of 10 CFR part 20. The staff has found that the radiological environmental impacts from the action are bounded by the impacts evaluated by NUREG–1496, Volumes 1–3, ‘‘Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Facilities’’ (ML042310492, ML042320379, and ML042330385). Additionally, no non-radiological or cumulative impacts were identified. On the basis of the EA, the NRC has concluded that there are no significant environmental impacts from the proposed action, and has determined not to prepare an environmental impact statement for the proposed action. IV. Further Information Documents related to this action, including the application for the license amendment and supporting documentation, are available electronically at the NRC’s Electronic Reading Room at https://www.nrc.gov/ reading-rm/adams.html. From this site, you can access the NRC’s Agencywide Document Access and Management System (ADAMS), which provides text and image files of NRC’s public documents. The ADAMS accession numbers for the documents related to this Notice are: Environmental Assessment Related to Issuance of a License Amendment of U.S. Nuclear Regulatory Commission Materials License No. 29–30389–01, DGI Biotechnologies, LLC in Edison, New Jesey (ML061070474); and Final Status Survey Results for DGI Biotechnologies, LLC Facility, 40 Talmadge Road, Edison, New Jersey (ML052840126). Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 25613 ADAMS, should contact the NRC PDR Reference staff by telephone at (800) 397–4209 or (301) 415–4737, or by email to pdr@nrc.gov. Documents related to operations conducted under this license not specifically referenced in this Notice may not be electronically available and/ or may not be publicly available. Persons who have an interest in reviewing these documents should submit a request to NRC under the Freedom of Information Act (FOIA). Instructions for submitting a FOIA request can be found on the NRC’s Web site at https://www.nrc.gov/reading-rm/ foia/foia-privacy.html. Dated at King of Prussia, Pennsylvania this 20th day of April, 2006. For the Nuclear Regulatory Commission. James P. Dwyer, Chief, Commercial and R&D Branch, Division of Nuclear Materials Safety, Region I. [FR Doc. E6–6505 Filed 4–28–06; 8:45 am] BILLING CODE 7590–01–P OFFICE OF MANAGEMENT AND BUDGET Executive Office of the President; Acquisition Advisory Panel; Notification of Upcoming Meetings of the Acquisition Advisory Panel Office of Management and Budget, Executive Office of the President. ACTION: Notice of Federal Advisory Committee Meetings. AGENCY: SUMMARY: The Office of Management and Budget announces five meetings of the Acquisition Advisory Panel (AAP or ‘‘Panel’’) established in accordance with the Services Acquisition Reform Act of 2003. DATES: There are five meetings announced in this Federal Register Notice. Public meetings of the Panel will be held on May 18th, May 31st, June 14th, July 7th and July 21st 2006. All meetings will begin at 9 a.m. Eastern Time and end no later than 5 p.m. ADDRESSES: Except for the July 7th meeting, all public meetings will be held at the Small Business Administration (SBA), 409 Third Street, SW., Washington, DC, 2nd Floor Eisenhower Conference Room (Metro stop at building: Federal Center Southwest, Orange or Blue Lines). The July 7th meeting will be held at the new FDIC Building, 3501 N. Fairfax Drive, Arlington, VA 22226, Room 203. This facility is a quarter of a block off of the Orange Line metro stop for Virginia Square. The public must pre-register E:\FR\FM\01MYN1.SGM 01MYN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 71, Number 83 (Monday, May 1, 2006)]
[Notices]
[Page 25613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-6505]



[[Page 25613]]

=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 030-34437]


Notice of Availability of Environmental Assessment and Finding of 
No Significant Impact for License Amendment for DGI Biotechnologies, 
LLC's Facility in Edison, NJ

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of Availability.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Joseph Nick, Commercial and R&D 
Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale 
Road, King of Prussia, Pennsylvania 19406, telephone (610) 337-5056, 
fax (610) 337-5269; or by e-mail: JLN@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Introduction

    The U.S. Nuclear Regulatory Commission (NRC) is considering the 
issuance of a license amendment to DGI Biotechnologies, LLC (DGI) for 
Materials License No. 29-30389-01, to authorize release of its facility 
in Edison, New Jersey for unrestricted use and terminate the license. 
NRC has prepared an Environmental Assessment (EA) in support of this 
proposed action in accordance with the requirements of 10 CFR part 51. 
Based on the EA, the NRC has concluded that a Finding of No Significant 
Impact (FONSI) is appropriate. The amendment will be issued following 
the publication of this Notice.

II. EA Summary

    The purpose of the proposed action is to authorize the release of 
the licensee's Edison, New Jersey facility for unrestricted use and 
terminate the license. DGI was authorized by NRC from 1997 to use 
radioactive materials for research and development purposes at the 
site. In 2003, DGI ceased operations with licensed materials at the 
Edison site and the DGI facility was taken over by Antyra, Inc. 
(Antyra). On September 28, 2005, Antyra requested that NRC release the 
facility for unrestricted use. Antyra has conducted surveys of the 
facility and provided information to the NRC to demonstrate that the 
site meets the license termination criteria in subpart E of 10 CFR part 
20 for unrestricted release.
    The NRC staff has prepared an EA in support of the license 
amendment. The facility was remediated and surveyed prior to the 
licensee requesting the license amendment. The NRC staff has reviewed 
the information and final status survey submitted by Antyra. Based on 
its review, the staff has determined that there are no additional 
remediation activities necessary to complete the proposed action. 
Therefore, the staff considered the impact of the residual 
radioactivity at the facility and concluded that since the residual 
radioactivity meets the requirements in subpart E of 10 CFR part 20, a 
Finding of No Significant Impact is appropriate.

III. Finding of No Significant Impact

    The staff has prepared the EA (summarized above) in support of the 
license amendment to terminate the license and release the facility for 
unrestricted use. The NRC staff has evaluated Antyra's request and the 
results of the surveys and has concluded that the completed action 
complies with the criteria in subpart E of 10 CFR part 20. The staff 
has found that the radiological environmental impacts from the action 
are bounded by the impacts evaluated by NUREG-1496, Volumes 1-3, 
``Generic Environmental Impact Statement in Support of Rulemaking on 
Radiological Criteria for License Termination of NRC-Licensed 
Facilities'' (ML042310492, ML042320379, and ML042330385). Additionally, 
no non-radiological or cumulative impacts were identified. On the basis 
of the EA, the NRC has concluded that there are no significant 
environmental impacts from the proposed action, and has determined not 
to prepare an environmental impact statement for the proposed action.

IV. Further Information

    Documents related to this action, including the application for the 
license amendment and supporting documentation, are available 
electronically at the NRC's Electronic Reading Room at https://
www.nrc.gov/reading-rm/adams.html. From this site, you can access the 
NRC's Agencywide Document Access and Management System (ADAMS), which 
provides text and image files of NRC's public documents. The ADAMS 
accession numbers for the documents related to this Notice are: 
Environmental Assessment Related to Issuance of a License Amendment of 
U.S. Nuclear Regulatory Commission Materials License No. 29-30389-01, 
DGI Biotechnologies, LLC in Edison, New Jesey (ML061070474); and Final 
Status Survey Results for DGI Biotechnologies, LLC Facility, 40 
Talmadge Road, Edison, New Jersey (ML052840126). Persons who do not 
have access to ADAMS or who encounter problems in accessing the 
documents located in ADAMS, should contact the NRC PDR Reference staff 
by telephone at (800) 397-4209 or (301) 415-4737, or by e-mail to 
pdr@nrc.gov.
    Documents related to operations conducted under this license not 
specifically referenced in this Notice may not be electronically 
available and/or may not be publicly available. Persons who have an 
interest in reviewing these documents should submit a request to NRC 
under the Freedom of Information Act (FOIA). Instructions for 
submitting a FOIA request can be found on the NRC's Web site at https://
www.nrc.gov/reading-rm/foia/foia-privacy.html.

    Dated at King of Prussia, Pennsylvania this 20th day of April, 
2006.

    For the Nuclear Regulatory Commission.
James P. Dwyer,
Chief, Commercial and R&D Branch, Division of Nuclear Materials Safety, 
Region I.
 [FR Doc. E6-6505 Filed 4-28-06; 8:45 am]
BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.